RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis

被引:180
|
作者
Gohda, J
Akiyama, T
Koga, T
Takayanagi, H
Tanaka, S
Inoue, J
机构
[1] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Dept Canc Biol,Minato Ku, Tokyo 1088639, Japan
[2] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 113, Japan
[3] Tokyo Med & Dent Univ, Dept Cellular Physiol Chem, Bunkyo Ku, Tokyo, Japan
来源
EMBO JOURNAL | 2005年 / 24卷 / 04期
关键词
bone remodeling; CD40; NFAT; NF-kappa B; RANK;
D O I
10.1038/sj.emboj.7600564
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RANK and CD40 activate NF-kappaB and MAPKs to similar levels via TRAF6. Even though overexpression of TRAF6 results in osteoclast formation, RANK but not CD40 promotes osteoclastogenesis. To understand the molecular basis for RANK- specific activity in osteoclastogenesis, we created an osteoclast formation system driven by antihuman CD40 antibody- mediated stimulation of a chimeric receptor, h40/ mRK, which consists of the extracellular domain of human CD40 and the transmembrane and cytoplasmic domains of mouse RANK. By introducing mutations into three TRAF6- binding sites of RANK, we found that h40/ mRK with a single TRAF6- binding site efficiently induced Ca2+ oscillation and expression of NFATc1, a master switch in osteoclastogenesis, whereas CD40 carrying a single TRAF6- binding site did not. However, expression of CD40 that was approximately 100 times greater than that of h40/ mRK resulted in osteoclast formation, indicating that the RANK - TRAF6 signal is more potent than the CD40 - TRAF6 signal in terms of NFATc1 activation and osteoclastogenesis. These results suggest that RANK may harbor a specific domain that amplifies TRAF6 signaling.
引用
收藏
页码:790 / 799
页数:10
相关论文
共 50 条
  • [1] Proteasome Inhibitors Attenuate Osteoclastogenesis and Bone Resorption via the Modulation of RANK-mediated TRAF6, p62 and IκB-α Signaling
    Ang, E. S.
    Pavlos, N.
    Chai, T.
    Yip, K.
    Rea, S.
    Ratajczak, T.
    Zheng, M.
    Xu, J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S153 - S153
  • [2] HSP90 Exacerbates Bone Destruction in Rheumatoid Arthritis by Activating TRAF6/NFATc1 Signaling
    Wang, Qian
    Kong, Xiangying
    Guo, Wanyi
    Liu, Liling
    Tian, Yage
    Tao, Xueying
    Lin, Na
    Su, Xiaohui
    INFLAMMATION, 2024, 47 (01) : 363 - 375
  • [3] HSP90 Exacerbates Bone Destruction in Rheumatoid Arthritis by Activating TRAF6/NFATc1 Signaling
    Qian Wang
    Xiangying Kong
    Wanyi Guo
    Liling Liu
    Yage Tian
    Xueying Tao
    Na Lin
    Xiaohui Su
    Inflammation, 2024, 47 : 363 - 375
  • [4] Association of Variant Interactions in RANK, RANKL, OPG, TRAF6, and NFATC1 Genes with the Development of Osteonecrosis of the Femoral Head
    Chen, Bingpeng
    Du, Zhenwu
    Dong, Xiaoming
    Li, Zhaoyan
    Wang, Qingyu
    Chen, Gaoyang
    Zhang, Guizhen
    Song, Yang
    DNA AND CELL BIOLOGY, 2019, 38 (07) : 734 - 746
  • [5] (+)-Vitisin A Inhibits Osteoclast Differentiation by Preventing TRAF6 Ubiquitination and TRAF6-TAK1 Formation to Suppress NFATc1 Activation
    Chiou, Wen-Fei
    Huang, Yu-Ling
    Liu, Yen-Wenn
    PLOS ONE, 2014, 9 (02):
  • [6] Effects of CD137 Signaling on the expression of NFATc1 in mice VSMCs through TRAF6/JNK/AP-1 pathway
    Yuan, Xu
    Yan, Jinchuan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C183 - C184
  • [7] Linking IL-17 signaling to TRAF6 transcriptome activities during OC-or-/DDOC-mediated osteoclastogenesis
    Liu, Yenchun
    Chiang, Min Shyuan
    Wang, Yan Hsiung
    Teng, Yen Tung
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [8] Influence of type 2 diabetes on immunohistochemical detection of TRAF6, cFos and NFATC1 in the gingiva in cases of chronic periodontitis
    Mathangi, R.
    Shyamsundar, Vidyarani
    Meenakshi, A.
    Babu, N. Aravindha
    Vashum, Yaongamphi
    Shila, S.
    BIOTECHNIC & HISTOCHEMISTRY, 2023, 98 (07) : 492 - 500
  • [9] Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling
    Tomomura, Mineko
    Suzuki, Ryuichiro
    Shirataki, Yoshiaki
    Sakagami, Hiroshi
    Tamura, Nobuaki
    Tomomura, Akito
    PLOS ONE, 2015, 10 (06):
  • [10] Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca2+-NFATc1 signaling pathway
    Xiang-zhou Zeng
    Yue-yang Zhang
    Qin Yang
    Song Wang
    Bin-hua Zou
    Yan-hui Tan
    Min Zou
    Shu-wen Liu
    Xiao-juan Li
    Acta Pharmacologica Sinica, 2020, 41 : 229 - 236